2025
SJR Q1
JCR Q1 · 4,2
OA
18 matched articles
SCIE
Journal detail
Lupus Science and Medicine
- Publisher
- BMJ Publishing Group
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
20538790
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,442
- Quartile Q1
- H-Index 49
- Cites/doc 3,64
- Docs (3y) 273
- Cites (3y) 1.045
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,2
- 5Y JIF 4,3
- JCI 1,21
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Immunology Q1
- Medicine (miscellaneous) Q1
- Rheumatology Q1
Areas
- Immunology and Microbiology
- Medicine
WoS categories
- Rheumatology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,442 | 4,2 | 4,3 | 1,21 | Q1 | 49 |
| 2024 | Q1 | Q1 | 1,401 | 4 | 3,9 | 1,16 | Q1 | 43 |
| 2023 | Q1 | Q1 | 1,278 | 3,7 | 3,5 | 0,92 | Q1 | 43 |
| 2022 | Q1 | Q2 | 1,035 | 3,9 | 4,3 | 0,84 | Q2 | 43 |
| 2021 | Q1 | Q2 | 1,188 | 4,7 | 4,7 | 0,82 | Q2 | 43 |
| 2020 | Q1 | Q2 | 1,547 | 4,2 | 4,6 | 0,82 | Q2 | 43 |
| 2019 | Q1 | — | 1,501 | — | — | — | — | 43 |
| 2017 | Q1 | — | 1,625 | — | — | — | — | 43 |
| 2016 | Q1 | — | 1,248 | — | — | — | — | 43 |
| 2015 | Q2 | — | 0,747 | — | — | — | — | 43 |
| 2014 | — | — | — | — | — | — | — | 43 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | RHEUMATOLOGY | SCIE | Q1 | Q1 | 13/58 |
| 2024 | RHEUMATOLOGY | SCIE | Q1 | Q1 | 14/58 |
| 2023 | RHEUMATOLOGY | SCIE | Q1 | Q1 | 14/57 |
| 2022 | RHEUMATOLOGY | SCIE | Q2 | Q2 | 17/34 |
| 2021 | RHEUMATOLOGY | SCIE | Q2 | Q2 | 16/34 |
| 2020 | RHEUMATOLOGY | SCIE | Q2 | Q2 | 17/34 |